<DOC>
	<DOCNO>NCT00637806</DOCNO>
	<brief_summary>To compare effect megestrol acetate concentrate suspension placebo caloric intake patient cancer-associated anorexia .</brief_summary>
	<brief_title>Treatment Cancer-associated Anorexia Using Megestrol Acetate Concentrated Suspension</brief_title>
	<detailed_description />
	<mesh_term>Weight Loss</mesh_term>
	<mesh_term>Anorexia</mesh_term>
	<mesh_term>Cachexia</mesh_term>
	<mesh_term>Megestrol</mesh_term>
	<mesh_term>Megestrol Acetate</mesh_term>
	<criteria>Cancer multiple type stage II , III , IV candidate chemotherapy ; may receive radiation therapy Fair , poor , poor appetite Cancerassociated anorexia/cachexia ( documented weight loss 2 % prior week , least 5 % within past 30 day , least 7.5 % prior 3 month , least 10 % prior 6 month ) Weight loss perceive associate diminished appetite Eastern Cooperative Oncology Group Performance score 0 , 1 , 2 Life expectancy great 3 month Alert mentally competent complete study assessment Women childbearing potential require use adequate reliable method contraception . Postmenopausal woman least 1 year Screening laboratory value must clinically significant ( exception per protocol ) Brain , head neck tumor may interfere food consumption AIDSrelated wasting Radiation therapy head neck , abdomen , pelvis within past 6 week , radiation therapy anticipate study result may interfere food consumption Presence condition interfere oral intake ability swallow Absence normally function gut Known mechanical obstruction alimentary biliary tract , malabsorption syndrome Intractable frequent vomit Clinically significant diarrhea History thromboembolic event , longterm anticoagulation thromboembolism Uncontrolled diabetes mellitus , symptomatic hypoadrenalism Poorly control hypertension congestive heart failure Pregnant/lactating female , plan become pregnant Use appetite stimulant within past 30 day Use parenteral nutrition tube feeding within past 1 week Chronic use steroid within past 3 month ( intermittent shortterm use allow ) Current use illicit substance Allergy , hypersensitivity , contraindication megestrol acetate</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Megestrol acetate</keyword>
	<keyword>Anorexia</keyword>
	<keyword>Cachexia</keyword>
	<keyword>Cancer</keyword>
	<keyword>Unintended weight loss</keyword>
	<keyword>Body weight</keyword>
	<keyword>Appetite</keyword>
	<keyword>Megace ES</keyword>
</DOC>